299 related articles for article (PubMed ID: 16731643)
21. Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate.
Oknińska M; Zambrowska Z; Zajda K; Paterek A; Brodaczewska K; Mackiewicz U; Szczylik C; Torbicki A; Kieda C; Mączewski M
Sci Rep; 2021 Sep; 11(1):18002. PubMed ID: 34504231
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
Bueno-Beti C; Sassi Y; Hajjar RJ; Hadri L
Methods Mol Biol; 2018; 1816():233-241. PubMed ID: 29987824
[TBL] [Abstract][Full Text] [Related]
23. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
24. Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension.
Henriques-Coelho T; Correia-Pinto J; Roncon-Albuquerque R; Baptista MJ; Lourenço AP; Oliveira SM; Brandão-Nogueira A; Teles A; Fortunato JM; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2885-90. PubMed ID: 15331358
[TBL] [Abstract][Full Text] [Related]
25. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension.
Falcão-Pires I; Gonçalves N; Henriques-Coelho T; Moreira-Gonçalves D; Roncon-Albuquerque R; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H2007-14. PubMed ID: 19346461
[TBL] [Abstract][Full Text] [Related]
26. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
27. Effects of a pure alpha/beta-adrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats.
Ishikawa M; Sato N; Asai K; Takano T; Mizuno K
Circ J; 2009 Dec; 73(12):2337-41. PubMed ID: 19822980
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure.
Redout EM; van der Toorn A; Zuidwijk MJ; van de Kolk CW; van Echteld CJ; Musters RJ; van Hardeveld C; Paulus WJ; Simonides WS
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1038-47. PubMed ID: 20061549
[TBL] [Abstract][Full Text] [Related]
29. Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart.
Handoko ML; Lamberts RR; Redout EM; de Man FS; Boer C; Simonides WS; Paulus WJ; Westerhof N; Allaart CP; Vonk-Noordegraaf A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1752-9. PubMed ID: 19734361
[TBL] [Abstract][Full Text] [Related]
30. Distinct right ventricle remodeling in response to pressure overload in the rat.
Mendes-Ferreira P; Santos-Ribeiro D; Adão R; Maia-Rocha C; Mendes-Ferreira M; Sousa-Mendes C; Leite-Moreira AF; Brás-Silva C
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H85-95. PubMed ID: 27199115
[TBL] [Abstract][Full Text] [Related]
31. Distinct time courses and mechanics of right ventricular hypertrophy and diastolic stiffening in a male rat model of pulmonary arterial hypertension.
Kwan ED; Vélez-Rendón D; Zhang X; Mu H; Patel M; Pursell E; Stowe J; Valdez-Jasso D
Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H702-H715. PubMed ID: 34448637
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat.
Zhang TT; Cui B; Dai DZ
Acta Pharmacol Sin; 2004 Feb; 25(2):226-30. PubMed ID: 14769214
[TBL] [Abstract][Full Text] [Related]
33. Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat.
Kögler H; Hartmann O; Leineweber K; Nguyen van P; Schott P; Brodde OE; Hasenfuss G
Circ Res; 2003 Aug; 93(3):230-7. PubMed ID: 12842921
[TBL] [Abstract][Full Text] [Related]
34. Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension.
Correia-Pinto J; Henriques-Coelho T; Roncon-Albuquerque R; Lourenço AP; Melo-Rocha G; Vasques-Nóvoa F; Gillebert TC; Leite-Moreira AF
Basic Res Cardiol; 2009 Sep; 104(5):535-45. PubMed ID: 19288153
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
[TBL] [Abstract][Full Text] [Related]
36. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
Gonzaga-Costa K; Vasconcelos-Silva AA; Rodrigues-Silva MJ; Rebouça CDSM; Duarte GP; Borges RS; Magalhães PJC; Lahlou S
Eur J Pharmacol; 2021 Apr; 897():173948. PubMed ID: 33609564
[TBL] [Abstract][Full Text] [Related]
37. Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload.
Borgdorff MA; Bartelds B; Dickinson MG; van Wiechen MP; Steendijk P; de Vroomen M; Berger RM
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H361-9. PubMed ID: 24878769
[TBL] [Abstract][Full Text] [Related]
38. Remodeling of gap junctional coupling in hypertrophied right ventricles of rats with monocrotaline-induced pulmonary hypertension.
Uzzaman M; Honjo H; Takagishi Y; Emdad L; Magee AI; Severs NJ; Kodama I
Circ Res; 2000 Apr; 86(8):871-8. PubMed ID: 10785509
[TBL] [Abstract][Full Text] [Related]
39. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
Gur S; Kadowitz PJ; Thammasitboon S; Lasky JA; Hellstrom WJ
J Androl; 2009; 30(5):495-504. PubMed ID: 19201699
[TBL] [Abstract][Full Text] [Related]
40. Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure.
Leineweber K; Brandt K; Wludyka B; Beilfuss A; Pönicke K; Heinroth-Hoffmann I; Brodde OE
Circ Res; 2002 Nov; 91(11):1056-62. PubMed ID: 12456492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
